Matches in SemOpenAlex for { <https://semopenalex.org/work/W2413805101> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2413805101 endingPage "43" @default.
- W2413805101 startingPage "939" @default.
- W2413805101 abstract "Piperazinedione was administered to 79 patients with solid tumors on an intermittent schedule with single doses of 1.5-36 mg/m2. Courses were usually repeated at 4-week intervals. Twenty-five patients with leukemia were treated at doses of 18-36 mg/m2 (occasionally for 2 successive days) every 1-4 weeks. Of 48 evaluable patients with malignant melanoma, three (6%) achieved partial remission and nine (20%) had stable disease. Eight of 17 (47%) patients with adenocarcinomas and one of two (50%) patients with lymphomas also had stable disease. Six of 14 (43%) patients with acute myelogenous leukemia showed hematologic improvement, as did one of 11 (9%) patients with blast cell crisis of chronic myelogenous leukemia. The principal toxic effect was myelosuppression, which occurred in 69% of the patients with solid tumors. Profound bone marrow aplasia occurred in 19% of the patients, resulting in six deaths (8%). Risk factors for marrow aplasia included extensive prior therapy, prior nitrosoureas, cumulative toxicity from piperazinedione, and abnormal liver function tests. The recommended doses for further studies are 9 mg/m2 for patients with risk factors for marrow aplasia, 12 mg/m2 for patients with prior therapy, 15 mg/m2 for previously untreated patients, and 24-36 mg/m2 for patients with acute leukemia." @default.
- W2413805101 created "2016-06-24" @default.
- W2413805101 creator A5002751190 @default.
- W2413805101 creator A5010968810 @default.
- W2413805101 creator A5027575595 @default.
- W2413805101 creator A5046099119 @default.
- W2413805101 creator A5046102148 @default.
- W2413805101 creator A5057373535 @default.
- W2413805101 creator A5072786200 @default.
- W2413805101 creator A5086996458 @default.
- W2413805101 creator A5088721166 @default.
- W2413805101 date "1979-06-01" @default.
- W2413805101 modified "2023-09-26" @default.
- W2413805101 title "Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia." @default.
- W2413805101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/380802" @default.
- W2413805101 hasPublicationYear "1979" @default.
- W2413805101 type Work @default.
- W2413805101 sameAs 2413805101 @default.
- W2413805101 citedByCount "4" @default.
- W2413805101 crossrefType "journal-article" @default.
- W2413805101 hasAuthorship W2413805101A5002751190 @default.
- W2413805101 hasAuthorship W2413805101A5010968810 @default.
- W2413805101 hasAuthorship W2413805101A5027575595 @default.
- W2413805101 hasAuthorship W2413805101A5046099119 @default.
- W2413805101 hasAuthorship W2413805101A5046102148 @default.
- W2413805101 hasAuthorship W2413805101A5057373535 @default.
- W2413805101 hasAuthorship W2413805101A5072786200 @default.
- W2413805101 hasAuthorship W2413805101A5086996458 @default.
- W2413805101 hasAuthorship W2413805101A5088721166 @default.
- W2413805101 hasConcept C126322002 @default.
- W2413805101 hasConcept C2776863199 @default.
- W2413805101 hasConcept C2776960273 @default.
- W2413805101 hasConcept C2778368355 @default.
- W2413805101 hasConcept C2778461978 @default.
- W2413805101 hasConcept C2780007613 @default.
- W2413805101 hasConcept C2911114841 @default.
- W2413805101 hasConcept C71924100 @default.
- W2413805101 hasConcept C90924648 @default.
- W2413805101 hasConceptScore W2413805101C126322002 @default.
- W2413805101 hasConceptScore W2413805101C2776863199 @default.
- W2413805101 hasConceptScore W2413805101C2776960273 @default.
- W2413805101 hasConceptScore W2413805101C2778368355 @default.
- W2413805101 hasConceptScore W2413805101C2778461978 @default.
- W2413805101 hasConceptScore W2413805101C2780007613 @default.
- W2413805101 hasConceptScore W2413805101C2911114841 @default.
- W2413805101 hasConceptScore W2413805101C71924100 @default.
- W2413805101 hasConceptScore W2413805101C90924648 @default.
- W2413805101 hasIssue "6" @default.
- W2413805101 hasLocation W24138051011 @default.
- W2413805101 hasOpenAccess W2413805101 @default.
- W2413805101 hasPrimaryLocation W24138051011 @default.
- W2413805101 hasRelatedWork W11366620 @default.
- W2413805101 hasRelatedWork W1664561201 @default.
- W2413805101 hasRelatedWork W1979785276 @default.
- W2413805101 hasRelatedWork W1999796479 @default.
- W2413805101 hasRelatedWork W2008234626 @default.
- W2413805101 hasRelatedWork W2103694121 @default.
- W2413805101 hasRelatedWork W2265431702 @default.
- W2413805101 hasRelatedWork W2339556068 @default.
- W2413805101 hasRelatedWork W2413805101 @default.
- W2413805101 hasRelatedWork W2470849579 @default.
- W2413805101 hasVolume "63" @default.
- W2413805101 isParatext "false" @default.
- W2413805101 isRetracted "false" @default.
- W2413805101 magId "2413805101" @default.
- W2413805101 workType "article" @default.